204 related articles for article (PubMed ID: 17000558)
1. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
[TBL] [Abstract][Full Text] [Related]
2. The effects of a custom-made lead collar on dose rates of patients treated with 131I.
Stapel AG; van der Zant FM; Gommans GM; Boer RO; Reigman HI
Health Phys; 2009 May; 96(5 Suppl 2):S64-8. PubMed ID: 19359844
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
[TBL] [Abstract][Full Text] [Related]
4. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
Eschner W; Kobe C; Schicha H
Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
[TBL] [Abstract][Full Text] [Related]
5. [Iodine uptake and the effect of radioiodine treatment--status after the addition of iodine to salt].
Vej-Hansen A; Nygaard B
Ugeskr Laeger; 2005 Sep; 167(39):3684-7. PubMed ID: 16219216
[TBL] [Abstract][Full Text] [Related]
6. Therapy of large multinodular goitre using repeated doses of radioiodine.
Baczyk M; Pisarek M; Czepczyński R; Ziemnicka K; Gryczyńska M; Pietz L; Sowiński J
Nucl Med Commun; 2009 Mar; 30(3):226-31. PubMed ID: 19262285
[TBL] [Abstract][Full Text] [Related]
7. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
[TBL] [Abstract][Full Text] [Related]
8. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
9. Optimized dose planning of radioiodine therapy of benign thyroidal diseases.
Bockisch A; Jamitzky T; Derwanz R; Biersack HJ
J Nucl Med; 1993 Oct; 34(10):1632-8. PubMed ID: 8410273
[TBL] [Abstract][Full Text] [Related]
10. Estimating radiation absorbed dose of individuals nearby 131I-treated hyperthyroid patients.
Cui S; Jiao L; Tan J; Zhang G; Zhang H; Long W; Fan S; Zhang W
Health Phys; 2014 Mar; 106(3):365-9. PubMed ID: 25208013
[TBL] [Abstract][Full Text] [Related]
11. Isolation period prediction in patients with differentiated thyroid carcinoma treated after thyroidectomy by radioiodine-131.
Markou P; Chatzopoulos D
Hell J Nucl Med; 2004; 7(3):195-8. PubMed ID: 15841299
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
[TBL] [Abstract][Full Text] [Related]
14. Radiation exposure after permanent prostate brachytherapy.
Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
[TBL] [Abstract][Full Text] [Related]
15. [Results of fractionated radioiodine therapy in 696 patients with hyperthyroidism and 690 patients with non-toxic goiter].
Klein B; Klein E; Horster FA
Nuklearmedizin; 1989 Aug; 28(4):129-36. PubMed ID: 2780331
[TBL] [Abstract][Full Text] [Related]
16. Radiation Safety Precautions in (131)I Therapy of Graves' Disease Based on Actual Biokinetic Measurements.
Liu B; Tian R; Peng W; He Y; Huang R; Kuang A
J Clin Endocrinol Metab; 2015 Aug; 100(8):2934-41. PubMed ID: 26046966
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy.
Khanna CM; Magdam M; Ravishankar L; Dham DN; Chugh P
J Assoc Physicians India; 1995 Oct; 43(10):685-8. PubMed ID: 8773004
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy for thyroid volume reduction of large goitres.
Bachmann J; Kobe C; Bor S; Rahlff I; Dietlein M; Schicha H; Schmidt M
Nucl Med Commun; 2009 Jun; 30(6):466-71. PubMed ID: 19381116
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the factors responsible for over or under dose of 131 I therapy patients of hyperthyroidism.
Muhammad W; Faaruq S; Hussain A; Kakakhail MB; Fatmi S; Matiullah
Radiat Prot Dosimetry; 2008; 128(1):90-7. PubMed ID: 17533161
[TBL] [Abstract][Full Text] [Related]
20. [Radiation doses from patients undergoing yttrium-90 silicate knee radiosynovectomy].
Badiavas K; Chatzopoulos D; Markou P
Hell J Nucl Med; 2006; 9(1):65-8. PubMed ID: 16617401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
